Agendia
PrivateLast Round
Debt
May 1, 2020
Total Funding Raised
$154.65M
Company Overview
Agendia is a precision oncology company that provides genomic diagnostic and information solutions to aid physicians in making optimized decisions for breast cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Agendia Comparables
Compare Agendia with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PreludeDx | 88% | |
| Hologic, Inc. | 83% | |
| Veracyte | 81% | |
Agendia Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | May 1, 2020 | ||||
| VC Round | Jul 25, 2018 | ||||
| Grant | Dec 16, 2015 | ||||
| Debt | Mar 14, 2014 | ||||
| Private Equity | May 31, 2012 | ||||
Series E | Sep 22, 2009 |
Key People
Founding team and executive leadership
Agendia Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Norgine Ventures | Debt |
| Gilde Investment Management | Series A |
| Korys | Private Equity |
| European Commission | Grant |
| ING Corporate Investments | Series E, Private Equity, Series D |
| Gilde Healthcare | Series D, Series E, Private Equity, Series C, Series A |
| The Van Herk Group | Series A, Series E, Private Equity, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 20, 2026
MammaPrint test recognized in updated NCCN guidelines for breast cancer treatment.
- Oct 15, 2025
Uses Glidian platform for prior authorizations.
Agendia Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Agendia's valuation, stock price, and market status.